SLD 239
Thyroid-Lit. 50878
Haymart, M.R. et al.
Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer.
Thyroid-Lit. 50879
Esfandiari, N.H. et al.
Factors associated with diagnosis and treatment of thyroid microcarcinomas.
Thyroid-Lit. 50880
Martinez, J.A. et al.
Radiofrequency ablation of thyroid nodules: a long-term prospective study of 24 patients.
Thyroid-Lit. 50881
Deandrea, M. et al.
Long-term efficacy of a single session of RFA for benign thyroid nodules: a longitudinal 5-year observational study.
Thyroid-Lit. 50882
Papanastasiou, A. et al.
Thyroid nodules as a risk factor for thyroid cancer in patients with Graves´ disease: a systematic review and meta-analysis of observational studies in surgically treated patients.
Thyroid-Lit. 50883
Benvenga, S. et al.
Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis.
Thyroid-Lit. 50884
Underbjerg, L. et al.
Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: a cohort study.
Thyroid-Lit. 50885
Dhillon-Smith, R.K. et al.
Levothyroxine in women with thyroid peroxidise antibodies before conception.
Thyroid-Lit. 50886
Kitahara, C.M. et al.
Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism.
Thyroid-Lit. 50887
Nalla, P. et al.
Thyrotropin receptor antibody concentration and activity, several years after treatment for Graves’ disease
Thyroid-Lit. 50888
Barres, B. et al.
Stimulated thyroglobulin and thyroglobulin reduction index predict excellent response in differentiated thyroid cancers
Thyroid-Lit. 50889
Soydal, C. et al.
Risk factors for predicting osteoporosis in patients who receive thyrotropin suppressive levothyroxine treatment for differentiated thyroid carcinoma
Letzte Aktualisierung: 20.04.2020